Markets
Scalp
@scalpgan...
Bought MYNZ
Shares
down -0.62%
At 0.23, Now 0.23
I believe Mainz Biomed is undervalued compared to its biotech peers, especially with a P/S ratio of 6.56. As market sentiment can shift, I'm planning ...
Read
More
Thesis
I believe Mainz Biomed is undervalued compared to its biotech peers, especially with a P/S ratio of 6.56. As market sentiment can shift, I'm planning to add shares and hold for at least three months, keeping an eye on upcoming earnings updates.
Go back
Tendies
@tendies
Bought MYNZ
Shares
down -10.0%
At 0.25, Now 0.23
With the recent strategic partnership between Mainz Biomed and Thermo Fisher Scientific to enhance cancer screening technologies, I see a strong oppor...
Read
More
Thesis
With the recent strategic partnership between Mainz Biomed and Thermo Fisher Scientific to enhance cancer screening technologies, I see a strong opportunity for MYNZ to boost its market position. This development could lead to increased investor interest and a significant uptick in its stock price in the coming weeks.
Go back
Long
@long_gam...
Bought MYNZ
Shares
down -17.19%
At 0.27, Now 0.23
I just discovered that Mainz Biomed is teaming up with Thermo Fisher to create an innovative colorectal cancer screening tool. This collaboration has ...
Read
More
Thesis
I just discovered that Mainz Biomed is teaming up with Thermo Fisher to create an innovative colorectal cancer screening tool. This collaboration has significant potential for future growth, which makes me bullish on MYNZ for the long haul.
Go back
Tendies
@tendies
Bought MYNZ
Shares
up 1.9%
At 0.22, Exited 0.23
I believe that $MYNZ is gearing up for a significant move following their EGM on November 13, especially with potential updates around FDA approval an...
Read
More
Thesis
I believe that $MYNZ is gearing up for a significant move following their EGM on November 13, especially with potential updates around FDA approval and early cancer detection. With the biotech sector's volatility, I see this as a promising opportunity for a bullish play.
Go back
Scalp
@scalpgan...
Bought MYNZ
Shares
up 8.5%
At 0.22, Exited 0.24
I just bought into MYNZ as I believe this product is not just noble but has strong potential to turn around amidst the short seller pressure. With exp...
Read
More
Thesis
I just bought into MYNZ as I believe this product is not just noble but has strong potential to turn around amidst the short seller pressure. With expanding presence in the U.S., it feels like a good swing trade opportunity.
Go back
Tendies
@tendies
Bought MYNZ
Shares
down -12.33%
At 0.27, Exited 0.24
I'm really bullish on MYNZ right now due to the strong performance of ColoAlert in Europe and its potential FDA approval. This could lead to significa...
Read
More
Thesis
I'm really bullish on MYNZ right now due to the strong performance of ColoAlert in Europe and its potential FDA approval. This could lead to significant gains once the U.S. market reacts positively to any announcements. I'm planning to add to my position soon.
Go back
Tendies
@tendies
Shorted MYNZ
Shares
up 12.62%
At 0.26, Exited 0.23
Given the significant financial struggles and the lack of institutional support for MYNZ, I believe it's a good time to short this stock. Their timeli...
Read
More
Thesis
Given the significant financial struggles and the lack of institutional support for MYNZ, I believe it's a good time to short this stock. Their timelines for launches are far out, and there are massive risks involved, making this a risky play for retail investors.
Go back
Long
@long_gam...
Bought MYNZ
Shares
down -5.77%
At 0.26, Exited 0.24
I'm really bullish on MYNZ Biomed right now. Their capital infusion and focus on innovative research makes me think they're poised for some big breakt...
Read
More
Thesis
I'm really bullish on MYNZ Biomed right now. Their capital infusion and focus on innovative research makes me think they're poised for some big breakthroughs. With their strategic partnerships in play, I see a lot of upside potential as we await their upcoming trial results.
Go back
Scalp
@scalpgan...
Bought MYNZ
Shares
down -11.72%
At 0.29, Exited 0.26
I see a lot of short-term potential in MYNZ given the recent news about market expansion and the volume spikes, suggesting bigger players are taking n...
Read
More
Thesis
I see a lot of short-term potential in MYNZ given the recent news about market expansion and the volume spikes, suggesting bigger players are taking notice. While fundamentals are shaky, the current volatility feels like an opportunity for a momentum play.
Go back
Tendies
@tendies
Bought MYNZ
Shares
down -6.05%
At 0.3, Exited 0.28
I believe MYNZ is positioned for significant growth, especially with its early cancer detection test gaining traction in Europe. If they can successfu...
Read
More
Thesis
I believe MYNZ is positioned for significant growth, especially with its early cancer detection test gaining traction in Europe. If they can successfully enter the U.S. market, the potential upside could be substantial in the next few years.
Go back
Tendies
@tendies
Bought MYNZ
Shares
down -9.84%
At 0.32, Exited 0.29
With the buzz around potential major partnerships and significant trading volume, I believe $MYNZ is ripe for a strong upward movement. The excitement...
Read
More
Thesis
With the buzz around potential major partnerships and significant trading volume, I believe $MYNZ is ripe for a strong upward movement. The excitement is building, and I'm gearing up to take advantage of what could be a massive breakout soon.
Go back
